Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, Keith D., Bowlus, Christopher L., Boyer, James, Levy, Cynthia, Mayo, Marlyn·2019·Hepatology
DOI 10.1002/hep.30145

Cited by (924)

Items 601–700 of 924

  1. A Bibliometric Analysis of Immunological Research in Primary Biliary Cholangitis: Global Patterns and Emerging Directions
    Jinfeng Liu, Wentao Zhang, Bing Xu, Danfeng Ren, Yingren Zhao · 2025 · Cureus
  2. Colangiopatía pos-COVID-19, una enfermedad emergente: serie de casos
    Rafael Gregorio Peña Amaya, Rómulo Vargas, Ana María Leguizamó · 2023 · Revista Colombiana de Gastroenterología
  3. Role of liver biopsy in management of liver diseases without hepatic nodules following end of the interferon era: experience of a tertiary referral center
    Nermine Ahmed Ehsan, Maha Elsabaawy, Dina Sweed, Esraa Karman, Eman Abdelsameea, Anwar Abdelaleem Mohamed · 2022 · Clinical and Experimental Medicine
  4. Recent advances in diagnosis and management of chronic cholestatic liver diseases: expert consensus
    Shrikant V Mukewar · 2025 · International Journal of Research in Medical Sciences
  5. Co-occurrence of autoimmune liver disease and gallstones: a clinically overlooked phenomenon
    Yujie Hu, Man Liu, LI Shu-qian, Yinglan Ji, Yu‐Qing Su, Jie Yang, Xue Zhang, Simin Zhou, Liping Guo, Yanni Li et al. · 2025 · European Journal of Gastroenterology & Hepatology
  6. Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis
    Jingqin Hu, Yuqiang Mi, Li Wang, Feng Jiang, Ping Li · 2024 · Clinics and Research in Hepatology and Gastroenterology
  7. Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases
    Maria Concetta Sorrentino, Danilo Villalta, Teresa Carbone, Maria Grazia Alessio, Maria Giaele Infantino, Luigi Cinquanta, Gaia Deleonardi, Stefan Platzgummer, Maria Teresa Trevisan, Giampaola Pesce et al. · 2026 · Autoimmunity Reviews
  8. Characteristics of clinical, laboratory, and immunological manifestations in patients with anticentromere antibody-associated Sjögren's disease
    B. D. Chaltsev, Vladimir Ivanovich Vasilyev, S G Palshina et al. · 2020 · Modern Rheumatology Journal
  9. Overall Survival and Treatment Outcomes in Patients With Primary Biliary Cholangitis: A 10-Year Single-Center Retrospective Cohort Study
    Shunyapat Sirirattanakorn, Tanita Suttichaimongkol, Witsarut Manasirisuk, Kookwan Sawadpanich, Apichart Sangchan, Pisaln Mairiang, Wattana Sukeepaisarnjaroen, Chitchai Rattananukrom · 2026 · Journal of Clinical and Experimental Hepatology
  10. Primary biliary cholangitis presenting with granulomatous lung disease misdiagnosed as lung cancer: A case report
    Shan-Li Feng, Junyao Li, Chunling Dong · 2024 · World Journal of Clinical Cases
  11. PERSPECTIVES ON AUTOIMMUNE HEPATITIS
    Richard L. Pullen · 2020 · Gastroenterology Nursing
  12. Primary Biliary Cholangitis, Liver Transplantation, and Hepatocellular Carcinoma: A Mini-review
    Badi Rawashdeh, Allison B. Couillard, Aasem Rawshdeh, Hassan Aziz, James Phillip Esteban, Motaz A Selim · 2022 · Gene Expression
  13. Ursodeoxycholic Acid in Liver Cirrhosis: A Chinese Perspective
    Wenkang Gao, Zhonglin Li, Huikuan Chu, Hang Yuan, Lilin Hu, Lin Yao, Li Rita Zhang, Weijun Wang, Rong Lin, Ling Yang · 2022 · Springer eBooks
  14. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Anne‐Christin Beatrice Wilde, Lena Maria Greverath, Lara Marleen Steinhagen, Nina Wald de Chamorro, E Leicht, Janett Fischer, Toni Herta, Thomas Berg, Beate E. Preuß, Reinhild Klein et al. · 2022 · Journal of Clinical Medicine
  15. Emerging Therapeutics for Primary Biliary Cholangitis
    Eun Ju Cho · 2025 · Korean Journal of Gastroenterology
  16. Overlap Syndromes
    Nora Cazzagon, Olivier Chazouillères · 2021 · Springer eBooks
  17. Immune thrombocytopenic purpura in primary biliary cholangitis and localized cutaneous systemic sclerosis: case report and literature review
    Taiki Okumura, Takefumi Kimura, Yu Hihara, Katsuaki Inoue, Atsushi Maruyama, Satoru Joshita, Takeji Umemura · 2023 · Clinical Journal of Gastroenterology
  18. POS0717 AUTOIMMUNE LIVER DISEASE IN ANTICENTROMERE ANTIBODY POSITIVE PRIMARY SJOGREN'S SYNDROME
    B. D. Chaltsev, Anna Vasilyevna Torgashina, Evgeniya Sokol · 2021 · Annals of the Rheumatic Diseases
  19. HSC-derived exosomal miR-122-5p inhibits EMT and fibrosis of intrahepatic biliary epithelial cells to alleviate primary biliary cholangitis
    Yaqin Zhang, Ruofei Chen, Xueqing Yang, Long Qian, Bing Shen, Zongwen Shuai · 2025 · Frontiers in Immunology
  20. A Rare Case Presentation: Diagnosing Primary Biliary Cholangitis in a Male Patient With Concomitant Type 1 Diabetes
    Adejoke M Johnson, Ezekiel J Akpan, Supriya Kale, Anna Patel · 2021 · Cureus
  21. Risk of comorbidity of autoimmune liver disease in patients with inflammatory bowel disease: A single‐center case–control study in China
    Meng Yuan Zhang, Tian Ming Xu, Ying Hao Sun, Xiao Tian Chu, Gechong Ruan, Xiaoyin Bai, Hong Lv, Hong Bo Yang, Hui Jun Shu, Jiaming Qian · 2024 · Journal of Digestive Diseases
  22. Long-Standing Unresolved Primary Biliary Cholangitis Leading to Systemic Amyloid A Amyloidosis With Predominant Liver Involvement: A Death Case
    Yupeng Zhang, Jie Luo, Chun Wang · 2019 · The American Journal of Gastroenterology
  23. Lipidome remodeling in primary biliary cholangitis
    M. Rogalska, P. Rogalski, Aleksandra Andrzejuk, Agnieszka U. Błachnio-Zabielska, Piotrek Zabielski, R. Flisiak · 2026 · Lipids in Health and Disease
  24. Impact of the prognostic nutritional index on the recompensation of patients with decompensated primary biliary cholangitis
    Chunjiao Yu, Ni Fan, Mengyao Zheng, Zhaoda Duan, Wenjie Yang, Man Huang, Hongyan Xu, Mengyu Li, Shunyu Chen, Chaozhang Gu et al. · 2025 · Frontiers in Immunology
  25. Diagnostic value of anti-hexokinase 1 and anti-kelch-like 12 antibodies in primary biliary cholangitis patients
    Min Yang, Chao Hu, Jun Huang, Ying Fu, Qi Zhang, Yulan Cheng, Jie Lu, Guiling Li, Jun Zhang · 2024 · Journal of Laboratory Medicine
  26. Analysis of the Clinical Features and Risk Factors of Primary Biliary Cholangitis
    怡飞 杨 · 2022 · Advances in Clinical Medicine
  27. Long-term efficacy of ursodeoxycholic acid for the prevention of gallstone formation after gastrectomy in patients with gastric cancer: a randomized clinical trial
    Dong Kee Jang, Moon‐Won Yoo, Young Suk Park, Sun-Hwi Hwang, Young-Kyu Park, Oh Kyoung Kwon, Hoon Hur, Hong Man Yoon, Hyoung-il Kim, Hye Seong Ahn et al. · 2026 · International Journal of Surgery
  28. Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision
    Gina Choi, Arun B. Jesudian, Sammy Saab · 2025 · Digestive Diseases and Sciences
  29. Rare renal proximal tubular dysfunctions in primary biliary cholangitis
    Xiaoxiao Shi, Tianchen Guo, Yubing Wen, Wei Ye, Wenling Ye, Ke Zheng, Yan Qin, Xuemei Li, Fengchun Zhang, Limeng Chen · 2024 · Renal Failure
  30. Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena
    Mengqi Li, Sha Chen, Shuxiang Li, Tingting Lv, Buer Li, Shan Shan, Min� Li, Na Zeng, Qianyi Wang, Yuanyuan Kong et al. · 2024 · Therapeutic Advances in Gastroenterology
  31. Holistic Patient Care in Primary Biliary Cholangitis: Managing Both the Disease and the Symptoms
    Eleanor Roberts · 2022 · EMJ Hepatology
  32. Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis
    Sha Chen, Meng Qi Li, Bu Er Li, Ting Lv, Shu Xiang Li, Shan Shan, Min� Li, Yuanyuan Kong, Dong Hui Zhang, Hong Ma et al. · 2023 · Journal of Digestive Diseases
  33. Extemporaneous Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
    Antonio Lopalco, Oriana Boscolo, Annalisa Cutrignelli · 2026 · Pharmaceutics
  34. Long‐Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long‐Term Safety Extension
    Christopher L. Bowlus, Frederik Nevens, Kris V. Kowdley, Alan Bonder, Thomas A. Capozza, Jing Li, Radhika Nair, Michael A Trauner, David E. Jones · 2026 · Alimentary Pharmacology & Therapeutics
  35. Autoantibodies profile in autoimmune liver diseases and chronic viral hepatitis
    Rehab Ahmed Rabie · 2024 · Egyptian journal of Immunology
  36. Randomized Controlled Trial Evidence on Peroxisome Proliferator‐Activated Receptor (PPAR) Agonists in Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis
    Marrium Sultan Dar, Tooba Fatima, Syeda Dua Azhar, Zuhaa Rehman, Muhammad Affan, Yusra Muhammad Saleem, Saqib Ali, Fabiha Athar, Sara Ishaq, Noor ul Ain et al. · 2025 · International Journal of Hepatology
  37. The impact of deep response to ursodeoxycholic acid in primary biliary cholangitis – should it be the new clinical standard?
    Adrielly Martins, Cynthia Levy · 2025 · Current Opinion in Gastroenterology
  38. Hepatic stellate cell-derived exosome miR-122-5p targets TNFRSF19 to inhibit EMT and fibrosis in intrahepatic biliary epithelial cells via the p38 MAPK pathway
    Yaqin Zhang, Xiangzhi Zhang, Ruofei Chen, Ziying Jiao, Bing Q. Shen, Zongwen Shuai · 2023 · Research Square
  39. Assessing and managing symptom burden and quality of life in primary sclerosing cholangitis patients
    Josiah D. McCain, David M. H. Chascsa, Keith D. Lindor · 2021 · Expert Opinion on Orphan Drugs
  40. Colangitis (ex-cirrosis) biliar primaria
    Alexandre E. Pariente · 2021 · EMC - Tratado de Medicina
  41. Case 4-2023: A 56-Year-Old Man with Abnormal Results on Liver Testing
    Irun Bhan, Esperance A. K. Schaefer, William R. Bradley, Josanna Rodriguez‐Lopez, Jerome Crowley, Bailey M. Hutchison · 2023 · New England Journal of Medicine
  42. Alkaline Phosphatase Normalization Occurs Less Frequently in Hispanic Patients With Primary Biliary Cholangitis
    Paul Yoon, Adriana Shen, Matthew Chen, Tara Foroohar, Isai Martinez Rios, Sade Brown, Jennifer L. Dodge, Brian T. Lee, Kali Zhou, Jeffrey Kahn et al. · 2026 · Clinical Gastroenterology and Hepatology
  43. A case of neuromyelitis optica spectrum disorders associated with primary biliary cholangitis: a twelve year follow-up study
    Toshiyuki Sakai, Masahide Kondo, Yosuke Kawana · 2022 · Rinsho Shinkeigaku
  44. Recomendaciones y criterios de calidad para mejorar el diagnóstico precoz de la colangitis biliar primaria
    Álvaro Díaz‐González, Noelia Fontanillas, Eva Gil-Hernández, Mercedes Guilabert, María‐Carlota Londoño, Mar Noguerol, Fernando Pérez Escanilla, José Joaquín Mira, Manel Santiñà · 2023 · Gastroenterología y Hepatología
  45. Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
    Yujiao Jin, Miaochan Wang, Yuan Liu, Aifang Xu · 2023 · Medicine
  46. Fibroblast growth factor 19 in combination with liver fibrosis markers for non-invasive diagnosis of primary biliary cholangitis-associated cirrhosis
    Wenlong Lu, Jiahui Chen, Yonggang Guo, Zhan Wang, Wei Gao, Mingjun Liu · 2025 · Clinica Chimica Acta
  47. Pruritus in primary biliary cholangitis: insights from the German PBC registry across secondary and tertiary care
    Toni Herta, Annegret Franke, Tobias Müller, Kerstin Stein, Heike Bantel, Rainer Günther, Gerald Denk, Philipp Alexander Reuken, Jörn Markus Schattenberg, Uwe Naumann et al. · 2025 · Annals of Hepatology
  48. Racial Differences in Liver Fibrosis Burden
    Michael L. Attanasi, Mathew J. Gregoski, Don C. Rockey · 2025 · Digestive Diseases and Sciences
  49. Editorial: rapid assessment of health‐related quality of life in primary biliary cholangitis—no excuse not to ask
    Aliya F. Gulamhusein, Nathan D. Jackson · 2019 · Alimentary Pharmacology & Therapeutics
  50. Letter: Double PBC ‐Related Autoantibody Positivity—How Essential Is It for Diagnosis?
    Alessandro Granito, Γεώργιος Παππάς, Paolo Muratori · 2026 · Alimentary Pharmacology & Therapeutics
  51. Beyond the Surface: Unveiling Hidden Hurdles to Primary Biliary Cholangitis Care
    Omar Shamaa, Abdul Ahmed, Loralee B. Rupp, Sheri Trudeau, Stuart C. Gordon · 2024 · Cureus
  52. Network meta-analysis: relative clinical efficacy and safety of elafibranor versus seladelpar as second-line treatment for patients with primary biliary cholangitis
    David E. Jones, Emily Combe, Harun Knight, Vicki Laskier-Owens, Shijie Ren, Tom Wright, E. Boing, Alex Pashley · 2026 · Journal of Comparative Effectiveness Research
  53. Risk factors for mortality in patients with primary biliary cholangitis: a nomogram to predict 5-year survival
    Yaxing Liu, Muyu Gao, Bin Li, Long Liu, Yao Liu, Ying Feng, Xiaojing Wang, Xianbo Wang, Guiqin Zhou · 2025 · Frontiers in Gastroenterology
  54. From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis
    Antonella Ruiu, Maria Pia Calabrese, Pietro Meschisi, Riccardo Plebani, Buzias Maria, Ana Lleò, Vincenzo Ronca · 2026 · European Journal of Internal Medicine
  55. A case of gastric cardia telangiectasias and primary biliary cirrhosis with hemorrhage
    Guo J · 2020 · Clinical Case Reports
  56. Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database
    Timothy E. Ritter, Christina Hanson, Christopher T. Fernandes, Joanna P. MacEwan, Xin Zhao, Craig S. Parzynski, Daniel Mercer, Erik Ness, Darren Wheeler, Kris V. Kowdley et al. · 2025 · Journal of Comparative Effectiveness Research
  57. High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study
    2023
  58. Primary biliary cholangitis
    Juan Pablo Trivella, Cynthia Levy · 2024 · Elsevier eBooks
  59. Glucosyl Hesperidin Benefits in Primary Biliary Cholangitis: A Multicenter, Open-Label, Randomized Controlled Study
    Kei Moriya, Kiyoshi Asada, Naoki Ozu, Shota Suzuki, Yukihisa Fujinaga, Masahide Enomoto, Yuki Tsuji, Yusuke Komeda, Junichi Hanatani, Daisuke Kaya et al. · 2026 · Clinical and Translational Gastroenterology
  60. GLOBE Score and UK ‐ PBC Risk Score Predict Long‐Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and Fenofibrate
    Shu Xiang Li, Bu Er Li, Min Li, Sha Chen, T T Lyu, Qian Yi Wang, Xiao Ming Wang, Yu Wang, Hong Ma, Xiaojuan Ou et al. · 2025 · Journal of Digestive Diseases
  61. Primary Biliary Cholangitis: Updates in Management and Goals of Treatment
    Kaitlyn Carlson, Madeleine Hines Salge, George T. Cholankeril · 2024 · Current Hepatology Reports
  62. Development and validation of a sensitive UPLC-MS/MS platform for comprehensive bile acid profiling in multiple biological matrices: Application to a 17α-ethinylestradiol-induced cholestatic rat model
    Gang Jiang, Yunli Fu, Ping Zhang · 2026 · Journal of Pharmaceutical and Biomedical Analysis
  63. Seladelpar for the Treatment of Primary Biliary Cholangitis
    Adonice Khoury, Jason Powell · 2025 · Annals of Pharmacotherapy
  64. Far From the Biliary Tree: A Case of Overlapping Autoimmune Liver Disease in a Patient Presenting With Sicca Symptoms
    Keifer P. Walsh, James Park · 2022 · Cureus
  65. Management of Cholestatic Pruritus in Primary Biliary Cholangitis: Ileal Bile Acid Transporter Inhibition and Holistic Care
    Eleanor Roberts · 2023 · EMJ Hepatology
  66. Biochemical and Plasma Lipid Responses to Pemafibrate in Patients With Primary Biliary Cholangitis and Dyslipidemia: A Four-Year Analysis
    Hiroyuki Kobayashi, Ayumi Sugiura, Mizuki Koyama-Otagiri, Takayuki Nimura, Yukifumi Kurasawa, Haruaki Shirakawa, Satoru Joshita · 2025 · Cureus
  67. Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan
    2023
  68. Treatment of intractable pruritus in patients with cholestasis with molecular adsorbents recirculating system dialysis: a case series
    Magdalena Antoszewska, Piotr Spychalski, Gerda Elisabeth Villadsen, Niels Kristian Aagaard · 2021 · Gastroenterology Review
  69. Odevixibat in progressive familial intrahepatic cholestasis: a profile of its use
    Young‐A Heo · 2022 · Drugs & Therapy Perspectives
  70. Optimizing clinic consultations in primary biliary cholangitis: International consensus recommendations
    Heike Bantel, Gideon Morris Hirschfield, David E. Jones, Kris V. Kowdley, Ana Lleò, Robert Mitchell-Thain, Ann Moore, Carol Roberts, Atsushi Tanaka · 2025 · Hepatology Communications
  71. Formulary Drug Review: Odevixibat
    Terri L. Levien, Danial E. Baker · 2022 · Hospital Pharmacy
  72. Epidemiology of autoimmune liver disease in Korea: Evidence from a nationwide real-world database
    2023
  73. Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study
    Elizabeth E. Williams, Craig Steven Lammert, Raj Vuppalanchi · 2026 · Digestive Diseases and Sciences
  74. Factors associated with progression and outcomes of primary biliary cholangitis: A cohort study, 2010-2019
    sayed mohamad javad sajadi, Babak Tamizifar, Mohammad Hossein Sanei, Anahita Babak · 2024 · Journal of Research in Medical Sciences
  75. Functional investigation and two-sample Mendelian randomization study of primary biliary cholangitis hub genes
    Yunchuan Yang, Xiang Ma, Chi Zhou, Nan Xu, Ding Ding, Zhongzheng Ma, Lei Zhou, Peiyuan Cui · 2024 · World Journal of Clinical Cases
  76. Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study
    Robert Gareth Gish, Joanna P. MacEwan, Yutong Liu, Dannielle S. Lebovitch, Radhika Nair, Leona Bessonova, Jing Li, Zobair M. Younossi · 2026 · Journal of Comparative Effectiveness Research
  77. Risk factors for esophagogastric variceal-related poor outcomes in primary biliary cholangitis: A prospective cohort study
    Lin Han, Huan Xie, Xue-Mei Ma, Xiao-Long Lu, Jun Zhao, Qing-Sheng Liang, Zheng-Sheng Zou, Jing-Feng Bi, Bo Jin, Ying Sun · 2024 · iLiver
  78. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases
    Alexey S. Dorofeev, Elena Nikolaevna Aleksandrova, Alexander A. Novikov, Салиев Кирилл Германович, Yu.G. Sandler, E. V. Vinnitskaya · 2022 · Russian Clinical Laboratory Diagnostics
  79. What Do We Know About the Symptoms and Palliative Care Needs of People Affected by Liver Disease?
    Mina O. Rakoski, Lissi Hansen, Manisha Verma, Christopher D. Woodrell · 2023 · Elsevier eBooks
  80. Predicting Risk in Primary Biliary Cholangitis
    Eun Ju Cho · 2023 · Gut and Liver
  81. Utility of pretreatment GLOBE score as a non-invasive prognostic tool in primary biliary cholangitis
    Manabu Hayashi, Kazumichi Abe, Naoto Abe, Tatsuro Sugaya, Yosuke Takahata, Masashi Fujita, Hiromasa Ohira · 2026 · Immunological Medicine
  82. Frequency of antithyroid antibodies in patients with primary biliary cholangitis
    Mariam Ghozzi, Amani Mankaï, Zeineb Ben Chedly · 2023 · Laboratory Medicine
  83. Clinical characteristics of dyslipidemia in patients with primary biliary cholangitis: a single-center experience in China
    Xu Wang, Tihong Shao, Ran Tian, Jia Liu, Yi Wei, Li Wang, Fengchun Zhang · 2025 · Clinical Rheumatology
  84. Abordaje del paciente con colestasis y síndrome ictérico. Posicionamiento científico conjunto AMH, AMG, AMEG
    Raúl Contreras-Omaña, J.A. Velarde-Ruiz Velasco, Graciela Castro‐Narro, Omar Edel Trujillo-Benavides, Felipe Zamarripa-Dorsey, Ángel Andrés Reyes Dorantes, Linda Elsa Muñoz-Espinosa, I. Aiza-Haddad, Mauricio Castillo-Barradas, Eira Cerda Reyes et al. · 2021 · Revista de Gastroenterología de México
  85. Mechanisms linking primary biliary cholangitis and osteoporosis: A combined clinical and molecular analysis
    Hongyu Li, Xinya Guo, Qiaowei Fan · 2026 · Medicine
  86. Immune Complex-Mediated Membranoproliferative Glomerulonephritis Secondary to Primary Biliary Cholangitis: A Rare Case Report
    Kadir Intas, Gülay Ulusal Okyay, Arzu Sağlam · 2024 · EMJ Nephrology
  87. Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective
    Christopher L. Bowlus, Paulo Lisboa Bittencourt, Billal Bobat, Aliya F. Gulamhusein, Kris V. Kowdley, Cynthia Levy, Ana Lleo, Xiong Ma, Atushi Tanaka · 2026 · The American Journal of Gastroenterology
  88. Colangite (ex cirrosi) biliare primitiva
    Alexandre E. Pariente · 2021 · EMC - AKOS - Trattato di Medicina
  89. A Lasso-Cox Nomogram for Long-Term Survival Prediction in Primary Biliary Cholangitis
    Rutong Zhang, Lifeng Deng · 2025
  90. A nomogram model for predicting the risk of primary biliary cholangitis
    Suqin Wang, Zhaoxun Li, Xinwen Guo, Jiayan Tan, Caini Zhang, Huiqin Feng, Ming Sun, Bingxiang Li, Chenglu He, Ya Li · 2025 · Research Square
  91. Assessment of a chemiluminescence immunoassay for antimitochondrial antibody subtype M2 in the diagnosis of primary biliary cholangitis
    Yujiao Jin, Ying Wang, Aifang Xu · 2026 · Laboratory Medicine
  92. Vitamin D and Bone Metabolism in Non-Alcoholic, Non-Viral Liver Cirrhosis: A Pilot Study
    Olga Spasskaya, Горбачева Анна Максимовна, Anastasiia Lavreniuk, Бибик Екатерина Евгеньевна, I. N. Tikhonov, Еремкина Анна Константиновна, А. V. Khairieva, E. E. Litvinova, Artem Yu. Zhukov, N G Mokrysheva · 2026 · Obesity and metabolism
  93. Elafibranor in selected patients with primary biliary cholangitis and cirrhosis: An exploratory real-world cohort study
    Nargiz Nuruzade, Ulya Oruc, Georgios Konstantis, Moritz Passenberg, Arash Dooghaie Moghadam, Jan Best, Claudia Veltkamp, Florian Seltsam, Hartmut Schmidt, Katharina Willuweit et al. · 2026 · Therapeutic Advances in Gastroenterology
  94. Helicobacter pylori Eradication Therapy–Associated Drug-Induced Liver Injury in a Patient With Primary Biliary Cholangitis
    Taro Nakajima, Takefumi Kimura, Yūki Yamashita · 2025 · Gastro Hep Advances
  95. A case of primary biliary cholangitis – diagnostic and treatment approaches
    Ana Fita, Elina Berliba, Eugen Tcaciuc, Angela I. PELTEC, Tatiana Burda · 2023 · Akademos
  96. Management of Clinically Significant Itch in Cholestatic Liver Disease
    Cynthia Levy, Gideon Morris Hirschfield, Andreas Emanuel Kremer, Kidist K. Yimam · 2023 · EMJ Hepatology
  97. Association between elevations in alkaline phosphatase and healthcare utilization and costs among individuals with primary biliary cholangitis in the United States
    Robert Gareth Gish, Michel Henry Mendler, Edward Mena, Chong Kim, Carla Perez, Yi Pan, Mihail Samnaliev, Diane Ito, Maria Agapova · 2025 · Journal of Medical Economics
  98. Features of the course of primary biliary cholangitis in women at different age periods: Literature review
    Irina A. Bulatova, Tatyana P. Shevlyukova, А. П. Щекотова, I. V. Shchekotova, Е В Попова · 2026 · Meditsinskiy sovet = Medical Council
  99. Dihydropyridopyrazine Functionalized Xanthene: Generating Stable NIR Dyes with Small‐Molecular Weight by Enhanced Charge Separation
    Xingxing Zhang, Feiyu Yang, Xinyu Zhao, Qian Wu, Long He, Zhe Li, Zhixuan Zhou, Tian‐Bing Ren, Xiaobing Zhang, Lin Yuan · 2024 · Angewandte Chemie
  100. Clinicopathological features of non-cirrhotic portal fibrosis in primary biliary cholangitis: a 15-year experience at a tertiary referral center
    Xiuhong Wang, Li Zhang, Shixuan Liu, T. Zhang, T. Wang, Dingrong Zhong · 2026 · Frontiers in Medicine